
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He, Liuhui Fu, Yiping Li, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 988-1000.e7
Open Access | Times Cited: 428
Yao He, Liuhui Fu, Yiping Li, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 988-1000.e7
Open Access | Times Cited: 428
Showing 1-25 of 428 citing articles:
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam, Romina E. Araya, April Huang, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5338-5356.e21
Open Access | Times Cited: 358
Khiem C. Lam, Romina E. Araya, April Huang, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5338-5356.e21
Open Access | Times Cited: 358
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 309
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 309
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 308
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 308
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 266
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 266
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 252
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 252
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang, Xingyu Rong, Zhao Gan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 4, pp. 581-594.e8
Open Access | Times Cited: 216
Hai Wang, Xingyu Rong, Zhao Gan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 4, pp. 581-594.e8
Open Access | Times Cited: 216
Short-chain fatty acids: linking diet, the microbiome and immunity
Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig
Nature reviews. Immunology (2024) Vol. 24, Iss. 8, pp. 577-595
Closed Access | Times Cited: 204
Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig
Nature reviews. Immunology (2024) Vol. 24, Iss. 8, pp. 577-595
Closed Access | Times Cited: 204
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 167
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 167
Dietary fiber and SCFAs in the regulation of mucosal immunity
Jian Tan, Laurence Macia, Charles R. Mackay
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 361-370
Closed Access | Times Cited: 156
Jian Tan, Laurence Macia, Charles R. Mackay
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 361-370
Closed Access | Times Cited: 156
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Huiqin Hou, Danfeng Chen, Kexin Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 225-235
Closed Access | Times Cited: 148
Huiqin Hou, Danfeng Chen, Kexin Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 225-235
Closed Access | Times Cited: 148
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 147
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 147
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 146
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 146
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 129
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 129
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 127
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 127
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Emily Klann, Upuli Dissanayake, Anjela Gurrala, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 117
Emily Klann, Upuli Dissanayake, Anjela Gurrala, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 117
Regulation of short-chain fatty acids in the immune system
Xiaofeng Liu, Jia-Hao Shao, Yi-Tao Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 93
Xiaofeng Liu, Jia-Hao Shao, Yi-Tao Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 93
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 93
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 93
Roseburia intestinalisgenerated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+T cells
Xing Kang, Changan Liu, Yanqiang Ding, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2112-2122
Open Access | Times Cited: 92
Xing Kang, Changan Liu, Yanqiang Ding, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2112-2122
Open Access | Times Cited: 92
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 89
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 89
Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections
Lisa-Marie Ney, Maximilian Wipplinger, Martha Grossmann, et al.
Open Biology (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 89
Lisa-Marie Ney, Maximilian Wipplinger, Martha Grossmann, et al.
Open Biology (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 89
The Current and Future Perspectives of Postbiotics
Bing Liang, Dongming Xing
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 6, pp. 1626-1643
Open Access | Times Cited: 86
Bing Liang, Dongming Xing
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 6, pp. 1626-1643
Open Access | Times Cited: 86
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring
Lauren E. Colbert, Molly B. El Alam, Rui Wang, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1945-1962.e11
Open Access | Times Cited: 83
Lauren E. Colbert, Molly B. El Alam, Rui Wang, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1945-1962.e11
Open Access | Times Cited: 83